Alisha Q. Nanda’s practice involves a wide range of complex civil litigation matters, including securities class action defense, financial services and insurance. She has litigated in state and federal courts around the U.S. and represented corporations and individuals in matters before the Securities and Exchange Commission (SEC).

Bio

Ms. Nanda’s experience includes representing:

  • a pharmaceutical company and certain of its officers and directors in a putative securities class action and a related derivative suit following the FDA’s disclosure of safety events concerning an approved drug;
  • a data protection company and certain of its officers and directors in a putative securities class action and a related derivative suit concerning disclosures regarding a new product and the company’s financial guidance;
  • underwriting syndicates in putative securities class actions concerning disclosures in connection with IPOs and secondary offerings of companies in the pharmaceutical and technology sectors;
  • a health care technology company and certain of its officers and directors in a securities class action concerning disclosures in connection with its IPO; a related derivative suit was dismissed;
  • a pharmaceutical company and certain of its officers and directors in securing the dismissal of a putative securities class action concerning the company’s cash projections and the board’s evaluation of strategic alternatives;
  • companies in various SEC investigations concerning, for example, suspicious activity reporting under the Bank Secrecy Act, purported trading improprieties, accounting issues and other compliance matters;
  • a mutual life insurance company in a purported class action challenging the company’s calculation of the amount of surplus it may retain under state law;
  • an investment bank in a purported class action involving antitrust claims concerning a number of leveraged buyout transactions, which resulted in the dismissal of all claims on summary judgment;
  • an insurance company in a purported class action challenging a proxy regarding bylaw amendments and demanding inspection of “books and records,” which resulted in the dismissal of all claims and subsequently was affirmed by the Appeals Court of Massachusetts;
  • an insurance company in dismissing a purported class action alleging that the company breached its contractual duties to variable annuity and variable life insurance policyholders by implementing a volatility management strategy in certain portfolios;
  • an investment adviser in a lawsuit brought by a state employees’ retirement system involving allegations of improper “market timing” trading in mutual funds, which resulted in the dismissal of all claims on summary judgment and subsequently was affirmed by a Texas state court of appeals; and
  • an insurance company in an appeal before the Eighth Circuit Court of Appeals involving a reinsurance policy and the legal doctrine of “follow-the-fortunes,” which resulted in a complete victory for the client.

In 2019, she was appointed to the Massachusetts Judicial Nominating Commission, which advises the governor on candidates for judicial office across the commonwealth. Ms. Nanda is a member of the firm’s Attorney Recruiting and Diversity committees, a partner liaison for the firm’s Global LatinX Affinity Network and a member of the Hispanic National Bar Association.

Credentials

Education

  • J.D., Harvard Law School, 2003 (member, Harvard Law Review)
  • A.B., Harvard University, Harvard College, 1999 (magna cum laude)

Admissions

  • Massachusetts
  • New York

Experience

  • Law Clerk, Hon. William G. Young, U.S. District Court for the District of Massachusetts (2004)

Alisha Q. Nanda